摘要
围绕《新型冠状病毒感染的肺炎诊疗方案(试行第六版)》中的治疗试用药物,包括抗病毒药物、糖皮质激素和中药,从各药的作用机制、药物相互作用、药物不良反应等方面,综述新型冠状病毒肺炎(COVID-19)治疗中可能出现的不良反应及防治策略,为临床治疗方案的合理选择提供参考。
Based on the medication regimens recommended by Diagnosis and Treatment Scheme for COVID-19(Trial Version 6.0), including antiviral drugs, corticosteroids and traditional Chinese medicines, this article reviews the possible adverse reactions and their prevention and treatment strategy during the treatment of COVID-19 in terms of the mechanisms of action, drug interactions and adverse drug reactions, aiming to provide reference for the selection of reasonable therapeutic regimens.
作者
侯静静
龚慧
赵翊畅
徐萍
张毕奎
颜苗
HOU Jingjing;GONG Hui;ZHAO Yichang;XU Ping;ZHANG Bikui;YAN Miao(Department of Pharmacy,the Second Xiangyfa Hospital of Central South University,Changsha 410011,China;Institute of Clinical Pharmacy,Central South University,Changsha 410011,China;Toxicology Counseling Center of Hunan Province,Changsha 410011,China)
出处
《药学进展》
CAS
2020年第2期153-158,共6页
Progress in Pharmaceutical Sciences
关键词
COVID-19
抗病毒药物
药物不良反应
防治
磷酸氯喹
COVID-19
antiviral drug
adverse drug reaction
prevention and treatment
chloroquine phosphate
